249 related articles for article (PubMed ID: 30419741)
1. Early monitoring of fatty acid profile in children with attention deficit and/or hyperactivity disorder under treatment with omega-3 polyunsaturated fatty acids.
Checa-Ros A; Haro-García A; Seiquer I; Molina-Carballo A; Uberos-Fernández J; Muñoz-Hoyos A
Minerva Pediatr; 2019 Aug; 71(4):313-325. PubMed ID: 30419741
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of dietary supplementation with natural ω-3 polyunsaturated fatty acids on the visual acuity of school-age children with lower IQ or attention-deficit hyperactivity disorder.
Wu Q; Zhou T; Ma L; Yuan D; Peng Y
Nutrition; 2015; 31(7-8):935-40. PubMed ID: 26015389
[TBL] [Abstract][Full Text] [Related]
3. Effect of supplementation with long-chain ω-3 polyunsaturated fatty acids on behavior and cognition in children with attention deficit/hyperactivity disorder (ADHD): a randomized placebo-controlled intervention trial.
Widenhorn-Müller K; Schwanda S; Scholz E; Spitzer M; Bode H
Prostaglandins Leukot Essent Fatty Acids; 2014; 91(1-2):49-60. PubMed ID: 24958525
[TBL] [Abstract][Full Text] [Related]
4. Omega-3 and Omega-6 Polyunsaturated Fatty Acid Levels and Correlations with Symptoms in Children with Attention Deficit Hyperactivity Disorder, Autistic Spectrum Disorder and Typically Developing Controls.
Parletta N; Niyonsenga T; Duff J
PLoS One; 2016; 11(5):e0156432. PubMed ID: 27232999
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Omega-3/6 Fatty Acids, Methylphenidate, and a Combined Treatment in Children With ADHD.
Barragán E; Breuer D; Döpfner M
J Atten Disord; 2017 Mar; 21(5):433-441. PubMed ID: 24464327
[TBL] [Abstract][Full Text] [Related]
6. Reduced Symptoms of Inattention after Dietary Omega-3 Fatty Acid Supplementation in Boys with and without Attention Deficit/Hyperactivity Disorder.
Bos DJ; Oranje B; Veerhoek ES; Van Diepen RM; Weusten JM; Demmelmair H; Koletzko B; de Sain-van der Velden MG; Eilander A; Hoeksma M; Durston S
Neuropsychopharmacology; 2015 Sep; 40(10):2298-306. PubMed ID: 25790022
[TBL] [Abstract][Full Text] [Related]
7. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
Young GS; Conquer JA; Thomas R
Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
[TBL] [Abstract][Full Text] [Related]
8. Increased Erythrocyte Eicosapentaenoic Acid and Docosahexaenoic Acid Are Associated With Improved Attention and Behavior in Children With ADHD in a Randomized Controlled Three-Way Crossover Trial.
Milte CM; Parletta N; Buckley JD; Coates AM; Young RM; Howe PR
J Atten Disord; 2015 Nov; 19(11):954-64. PubMed ID: 24214970
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled trial investigating the effects of PCSO-524, a patented oil extract of the New Zealand green lipped mussel (Perna canaliculus), on the behaviour, mood, cognition and neurophysiology of children and adolescents (aged 6-14 years) experiencing clinical and sub-clinical levels of hyperactivity and inattention: study protocol ACTRN12610000978066.
Kean JD; Camfield D; Sarris J; Kras M; Silberstein R; Scholey A; Stough C
Nutr J; 2013 Jul; 12():100. PubMed ID: 23866813
[TBL] [Abstract][Full Text] [Related]
10. Investigation into the plasma concentration of ω3 polyunsaturated fatty acids in Japanese attention-deficit hyperactivity disorder patients.
Yonezawa K; Nonaka S; Iwakura Y; Kusano Y; Funamoto Y; Kanchi N; Yamaguchi N; Kusumoto Y; Imamura A; Ozawa H
J Neural Transm (Vienna); 2018 Sep; 125(9):1395-1400. PubMed ID: 29926268
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder.
Greenhill LL; Findling RL; Swanson JM;
Pediatrics; 2002 Mar; 109(3):E39. PubMed ID: 11875167
[TBL] [Abstract][Full Text] [Related]
12. Osmotic Release Oral System Methylphenidate Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Chinese Youth: 8-Week Comparative Efficacy and 1-Year Follow-Up.
Su Y; Yang L; Stein MA; Cao Q; Wang Y
J Child Adolesc Psychopharmacol; 2016 May; 26(4):362-71. PubMed ID: 26779845
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR™) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Phase III, Randomized, Double-Blind Study.
Wigal SB; Nordbrock E; Adjei AL; Childress A; Kupper RJ; Greenhill L
CNS Drugs; 2015 Apr; 29(4):331-40. PubMed ID: 25877989
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of a Chewable Methylphenidate Extended-Release Tablet in Children with Attention-Deficit/Hyperactivity Disorder.
Wigal SB; Childress A; Berry SA; Belden H; Walters F; Chappell P; Sherman N; Orazem J; Palumbo D
J Child Adolesc Psychopharmacol; 2017 Oct; 27(8):690-699. PubMed ID: 28557548
[TBL] [Abstract][Full Text] [Related]
15. Eicosapentaenoic and docosahexaenoic acids, cognition, and behavior in children with attention-deficit/hyperactivity disorder: a randomized controlled trial.
Milte CM; Parletta N; Buckley JD; Coates AM; Young RM; Howe PR
Nutrition; 2012 Jun; 28(6):670-7. PubMed ID: 22541055
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Polyunsaturated Fatty Acids (PUFA) in the Treatment of Attention Deficit Hyperactivity Disorder.
Assareh M; Davari Ashtiani R; Khademi M; Jazayeri S; Rai A; Nikoo M
J Atten Disord; 2017 Jan; 21(1):78-85. PubMed ID: 23160488
[TBL] [Abstract][Full Text] [Related]
17. Omega-3 fatty acids are inversely related to callous and unemotional traits in adolescent boys with attention deficit hyperactivity disorder.
Gow RV; Vallee-Tourangeau F; Crawford MA; Taylor E; Ghebremeskel K; Bueno AA; Hibbeln JR; Sumich A; Rubia K
Prostaglandins Leukot Essent Fatty Acids; 2013 Jun; 88(6):411-8. PubMed ID: 23664595
[TBL] [Abstract][Full Text] [Related]
18. Efficacy, Safety, and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder in the Laboratory Classroom Setting.
Childress AC; Kollins SH; Cutler AJ; Marraffino A; Sikes CR
J Child Adolesc Psychopharmacol; 2017 Feb; 27(1):66-74. PubMed ID: 27183299
[TBL] [Abstract][Full Text] [Related]
19. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
Kang KD; Yun SW; Chung U; Kim TH; Park JH; Park IH; Han DH
Hum Psychopharmacol; 2016 Mar; 31(2):76-82. PubMed ID: 26756111
[TBL] [Abstract][Full Text] [Related]
20. Behavioral and cognitive effects of docosahexaenoic acid in drug-naïve children with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled clinical trial.
Crippa A; Tesei A; Sangiorgio F; Salandi A; Trabattoni S; Grazioli S; Agostoni C; Molteni M; Nobile M
Eur Child Adolesc Psychiatry; 2019 Apr; 28(4):571-583. PubMed ID: 30246216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]